Shenzhen Cell Valley Biopharmaceutical Co., Ltd., Yunnan Cell Engineering Center Co., Ltd., and Kunming Shiguangji Biotechnology Co., Ltd. Reach Strategic Cooperation Agreement

Date:08-01  Hits:  Belong to:News

图片.png

Recently, Shenzhen Cell Valley Biopharmaceutical Co., Ltd., Yunnan Cell Engineering Center Co., Ltd., and Kunming Shiguangji Biotechnology Co., Ltd. formally announced the conclusion of a strategic cooperation agreement. The signing ceremony was held at the Yunnan Cell Engineering Center. This collaboration aims to establish a win-win and sustainable strategic partnership through close cooperation among the three parties, further promoting the exchange and collaboration between Guangdong and Yunnan provinces in the gene and cell industry, achieving complementary resource advantages, and jointly contributing to the advancement of the cell and gene industry.

图片.png

Chairman Professor Shi Yuanyuan stated that Shenzhen Cell Valley Biopharmaceutical Co., Ltd. would fully leverage its leading advantages in the cell and gene technology field to promote the application and adoption of more cutting-edge technologies through cooperation with Yunnan Cell Engineering Center Co., Ltd. and Kunming Shiguangji Biotechnology Co., Ltd.

Chairman Professor Ma Bo emphasized that Yunnan Cell Engineering Center Co., Ltd. is committed to providing high-quality cell products and technical support, and, leveraging Shenzhen Cell Valley's technological advantages and Kunming Shiguangji's innovative capabilities, will jointly advance the development of the gene and cell industry.

General Manager Professor Liu Xin stated that Kunming Shiguangji Biotechnology Co., Ltd. would fully utilize its innovative capabilities in the biotechnology field to explore more cooperation opportunities and promote progress in gene and cell technologies, together with Shenzhen Cell Valley and Yunnan Cell Engineering Center.

The three parties unanimously agreed that this cooperation would further strengthen the exchange and collaboration between Guangdong and Yunnan provinces in the gene and cell field, achieve resource sharing and complementary advantages, and jointly promote the high-quality development of the cell and gene industry.

The establishment of this strategic partnership not only marks an important step forward in the collaboration among the three enterprises in the gene and cell field, but also lays a solid foundation for deeper cooperation in broader areas in the future. The three parties will continue to work together, dedicated to advancing the innovation and development of gene and cell technologies and contributing to the cause of human health.


图片.png

About Yunnan Cell Engineering Center Co., Ltd. (YNCEC)

Yunnan Cell Engineering Center Co., Ltd. (YNCEC) is a limited liability company established in accordance with modern enterprise requirements by Shiguangji Biotechnology Co., Ltd. and Kunming National High-tech Industrial Development Zone State-owned Assets Management Co., Ltd. The company currently occupies a facility with a floor area of 55,000 square meters, dedicated to building a first-class technology sharing platform and cGMP advanced manufacturing platform for the cell industry. Combining "independent innovation + introduction of technology and products," the company focuses on constructing three major technology centers in Kunming High-tech Zone: "Cell Storage, Cell Preparation, and Cell Quality Testing and uation." Through close collaboration with the government, industry associations, and universities, it establishes a cell science education base and an international cell industry transfer and exchange center, attracting high-end talent and high-quality projects in the cell industry, providing project incubation and industrial support, and jointly building a cell industry cluster.


图片.png

About Kunming Shiguangji Biotechnology Co., Ltd.

Kunming Shiguangji Biotechnology Co., Ltd. was founded by a team of senior biopharmaceutical doctors and focuses on the development of technology products in the CGT field. The company has received the Yunnan Provincial Youth Entrepreneurship Governor's Award. It holds a controlling stake in Yunnan Cell Engineering Center and has established a comprehensive technical quality system. The company has built clinical-grade umbilical cord and dental pulp stem cell banks, as well as PBMC and PB-NK storage banks, with four stem cell and immune cell drug development pipelines in reserve and one product with a medical device filing number.


About Us
Scan to follow our latest newsScan to follow our latest news
Contact Us
400-800-1266

Working hours: Monday to Friday, 9:00-18:00

Contact:Ms. Lai

Email:laijiaqi@sz-cell.com

Address:No. 1, Rongtian Road, Jinsha Community, Kengzi Street, Pingshan District, Shenzhen, China (Hepure Biomedical Ecological Park)

Shenzhen Cell Valley Biopharmaceutical Co., Ltd. is a leading one-stop comprehensive outsourcing service provider for China’s cell and gene therapy industry. It is also among the first domestic CRO/CDMO enterprises to hold GMP-compliant industrial production capabilities for clinical-grade retroviral vectors. As a key project for the construction of Shenzhen’s public technical service platform for CRO/CDMO, the company has been listed in the city’s newly announced "20+8" strategic emerging industries initiative.
Shenzhen Cell Valley is equipped with the capacity to conduct standardized and industrialized production of GMP-grade cellular products including CAR-T cells. Its core production lines cover a full spectrum of cellular products such as CAR-T, CAR-NK, CAR-M, γδT, TIL and TCR-T. In addition, the company runs production lines for a diverse range of viral vectors (including RVV, LVV and AAV) and non-viral vectors, as well as for cellular raw materials for therapeutic development—such as exosomes, genetically engineered antibodies, cytokines, oncolytic viruses and vaccines.